Position in CDXS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$116,107
+$56,753 QoQ
Shares Held
51,375
+41.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $896,134,901 across 107 Biotechnology names. CDXS ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in CDXS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,107 | 51,375 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $59,354 | 36,414 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $27,864 | 17,095 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $165,229 | 67,717 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $166,900 | 68,402 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,024,755 | 380,950 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,477,331 | 309,713 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $613,449 | 199,172 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $670,486 | 216,286 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $564,155 | 161,649 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $365,274 | 119,762 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $71,712 | 37,943 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $134,302 | 47,965 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $186,763 | 45,112 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $124,426 | 26,701 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $148,718 | 24,541 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $332,753 | 31,812 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $566,225 | 27,460 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $983,003 | 31,436 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $788,095 | 33,882 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $365,007 | 16,108 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $321,169 | 14,031 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $284,881 | 13,050 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $141,772 | 12,076 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $143,662 | 12,602 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $227,652 | 20,399 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||